Conscience’s Post

Collaborating for Affordable Medications In the pursuit of healthcare accessibility, the affordability of medications is paramount and the power of collaboration is key in addressing the challenge of high drug costs. * Organizations, governments, and industry leaders are uniting to tackle this issue through advocacy, research, and direct assistance programs. * From innovative pricing models to partnerships between pharmaceutical companies and non-profits, collaborative efforts are making a positive impact on medication affordability. How You Can Get Involved: Readers are encouraged to support advocacy campaigns, volunteer with organizations, and spread awareness to contribute to the cause of affordable medications. Collaboration is key in the journey towards affordable medications, ensuring that no one has to sacrifice their health due to financial constraints. To learn more about chronic pain, visit our website www.10mg.co.uk #chronicpain #pain #painmanagement #health #technology #healthtech

In honor of #NationalPatientAdvocacyDay, Envision Pharma Group recognizes patients' vital role in shaping healthcare. We are resharing our blog from Jessica Krauser, Jasmine Patel, MPH, and Amanda Boughey that looks at how patient insights are influencing the development of new medicines: - Patient-focused drug development has a 19% higher success rate. - Involving patients early can speed up product launches by 2.5 years. - Patient advocacy has led to important changes in clinical trials and regulations. However, there are still challenges: - Regulatory hurdles - Proving long-term benefits - Budget limits - Need for cultural change within organizations We are committed to overcoming these challenges to develop better healthcare solutions. Read our full analysis on why patient involvement matters in medicine development: https://lnkd.in/eP6XJzpC #PatientAdvocacy #MedicineDevelopment #LifeSciences

This article by Jessica Krauser, Jasmine Patel, and Amanda Boughey highlights the crucial role of patient advocacy in the life sciences. At Envision Pharma Group, patients' voices guide every step of the healthcare journey—from research and development to communication and engagement. Patient advocacy is a cornerstone of how we shape the future of healthcare. By listening to and amplifying patient perspectives, we drive change, ensuring medical innovations meet the needs of those they are designed to help. The article explores how we’re integrating patient voices into our strategies, making advocacy a catalyst for action.

This week, pharma companies were invited to submit their documents to the #AccessToMedicinesIndex. The index is evolving, moving from focusing not only on commitments and processes but, importantly, on how many patients are actually reached. 🌍 Advancing Access to Medicines results in three top priorities for Pharma in the Months Ahead 🎯 1️⃣ Measuring #PatientReach: Beyond counting units sold, the emphasis now is on measuring the actual number of patients reached. The challenge lies in defining a universal indicator that spans a company's products and countries. 2️⃣ Holistic Access Strategies: Access barriers can hinder people from receiving essential care. Often, access teams and capacity building teams function independently. Creating a unified strategy that integrated product access with addressing barriers holds immense potential for enhancing patient reach. 3️⃣ Local Implementation Matters: Many implementation organisations pursue their unique priorities. Embedding local expertise is crucial for reducing access barriers, but companies must lead this by defining their overarching theory of change. Let's collectively drive positive outcomes in healthcare accessibility! 💊🤝 #ATMI #AccessToMedicines #HealthcareForAll #PharmaImpact #PartOfTheSolution

Enhancing Healthcare System Efficiency Through Innovation A report sponsored by Gilead explores the role of innovation in improving healthcare systems. It identifies nine barriers to innovation adoption, including technological obstacles and the willingness of clinicians and patients to use new technologies. The report highlights the importance of multistakeholder partnerships in overcoming these barriers and presents real-world examples of successful collaborations. It also discusses the impact of COVID-19 on healthcare systems and emphasizes the need for stakeholder collaboration to drive efficiency improvements and benefit patients and providers. For more details please click the link! https://lnkd.in/d4gEEXkJ #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #medicaldevices #pharmaceutical

Join us on Thursday 11th January for this Global Whispers live webinar at 1.00pm(GMT)/2.00pm(CET)/8.00am(EST), where we will be exploring best practice commercialisation strategy for healthcare products launching in the US market. Register now at: https://lnkd.in/erpF4qUt Clare Foy (Director – Global Market Access, Mtech Access) will be speaking to Janice MacLennan (Pharma and Medtech Brand Strategist and Founder of NMBLR) about how Market Access, HEOR, and Commercialisation Leads in Pharma and Medtech can best support overarching product and brand strategy. Using the US market as our case study, we will explore: ➡️ Setting up your product for success ➡️ US commercialisation routes for Pharma and Medtech ➡️ The relationship between brand strategy and market access ➡️ What Pharma can learn from Medtech’s approach to commercialisation ➡️ What Medtech innovators can learn from Pharma companies’ approach to launch Learn more about this webinar at: https://lnkd.in/e6jpApeH If you can't attend live, register nonetheless and we'll send you a link to the recording. #MarketAccess #brandstrategy #Pharma #Medtech #MedicalDevice #USA #launch #commercialisation

𝐋𝐞𝐚𝐫𝐧 𝐟𝐫𝐨𝐦 𝐨𝐮𝐫 𝐜𝐮𝐬𝐭𝐨𝐦𝐞𝐫𝐬 Watch this short video featuring Dr. Asif Qasim, practicing consultant cardiologist and CEO of MedShr. Dr. Qasim shares valuable insights on how Pharma can effectively engage with healthcare professionals. He discusses what matters to HCPs, strategies to raise awareness, and the importance of framing data within clinical implications to fuel peer-to-peer discussions. The video concludes with key points on how Pharma can support clinical practice. Don't miss these expert tips! This video is produced by the Pharmaceutical Marketing Society’s Digital Interest Group to address some our industries most pressing challenges in the digital space. It has been designed to inform and share good practice, but most importantly to generate discussion, collaboration, and progress. If you find value in the article then please like, share, and join in the conversation. #PMSociety, #DIG, With thanks to: Dave Pinnington, Jag Singh, Alison Rayner and of course Asif Qasim

Why am I writing the 'Patient Empowerment Manifesto'? The patient’s voice has always been a key factor in healthcare, yet it is often overlooked and undervalued. For far too long, patients have been seen as passive recipients of care, rather than active participants in their own health journey. This mindset needs to change, and the timing could not be more crucial.   We are now living in a society where patients are more informed and empowered than ever before. With the rise of social media and access to information, patients are no longer willing to simply follow doctor's orders without question. They want to be involved in the decision-making process and have their voices heard.   There is a growing recognition of the value of patient insights in healthcare research and development. The pharmaceutical industry, for example, has been increasingly incorporating patient input into drug development processes. This shift towards a more patient-centric approach is not only beneficial for patients, but also for the industry itself as it leads to improved treatments and better outcomes. despite this progress, there is still so much work to be done. The patient voice needs to be recognized and listened to now more than ever. While some people may argue that this is just a trend or a passing phase, the truth is that patient involvement in healthcare decision-making and research has been proven to lead to better outcomes. Patient's need a voice, and I have penned this book to help the industry improve trials by listening to the #patientvoice #healthcarereform #clinicaltrialadvocacy Researchreform

What Are Some Preventive Healthcare Companies In India? As India strives for a better future, it will need advanced healthcare infrastructure. These participants, ranging from large pharmaceutical corporations to research and diagnostic firms, are the unsung heroes who fight disease, promote health, and reshape the healthcare industry. In this blog, we will learn about the top healthcare product companies list in India, people who are willing to use their credibility and reputation to succeed. https://lnkd.in/gaMAkvbY